[ Price : $8.95]
Federal Register Notice: FDAs Risk Communication Advisory Committee meets 11/ to discuss and make recommendations on the agencys d...[ Price : $8.95]
Federal Register Notice: FDA announces the 2016 FDA Naloxone App Competition, a prize competition designed to help reduce deaths a...[ Price : $8.95]
A summary of an internal CDER dispute surrounding the approval of Sareptas controversial Duchenne drug Exondys 51 shows that Cente...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Option Care Enterprises, Jeffreys Drug Store, Sarkli/Repechage and ZO Skin Healt...[ Price : $8.95]
FDA rescinds a Teva Pharmaceutical Industries Special Protocol Assessment after two dosing options were discontinued in multiple s...[ Price : $8.95]
KemPharm decides to file a formal dispute resolution challenge to an FDA rejection of its claim of abuse deterrence for the labeli...[ Price : $8.95]
FDA approves a Med-El USA PMA for the Synchrony EAS (Electric Acoustic Stimulation) Hearing Implant System.[ Price : $8.95]
FDA announces a Naloxone App Competition, a public contest focused on developing a mobile phone application that can connect opioi...